Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 29 06 2023
revised: 12 10 2023
accepted: 27 10 2023
medline: 18 3 2024
pubmed: 12 1 2024
entrez: 12 1 2024
Statut: ppublish

Résumé

The function of perilipin 1 in human metabolism was recently highlighted by the description of PLIN1 variants associated with various pathologies. These include severe familial partial lipodystrophy and early onset acute coronary syndrome. Additionally, certain variants have been reported to have a protective effect on cardiovascular diseases. The role of this protein remains controversial in mice and variant interpretation in humans is still conflicting. This literature review has two primary objectives (i) to clarify the function of the PLIN1 gene in lipid metabolism and atherosclerosis by examining functional studies performed in cells (adipocytes) and mice and (ii) to understand the impact of PLIN1 variants identified in humans based on the variant's location within the protein and the type of variant (missense or frameshift). To achieve these objectives, we conducted an extensive analysis of the relevant literature on perilipin 1, its function in cellular models and mice, and the consequences of its mutations in humans. We also utilized bioinformatics tools and consulted the Human Genetics Cardiovascular Disease Knowledge Portal to enhance the pathogenicity assessment of PLIN1 missense variants.

Identifiants

pubmed: 38214891
pii: 7517630
doi: 10.1093/cvr/cvae005
doi:

Substances chimiques

Perilipin-1 0
Perilipin-2 0
Phosphoproteins 0
Plin1 protein, mouse 0
PLIN1 protein, human 0

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-248

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: none declared.

Auteurs

Camille Desgrouas (C)

Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France.

Tabea Thalheim (T)

Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France.

Mathieu Cerino (M)

Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France.
AP-HM, Service de Biochimie, Hôpital de la Timone 264 rue Saint Pierre 13005 Marseille, France.

Catherine Badens (C)

Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France.
AP-HM, Service de Biochimie, Hôpital de la Timone 264 rue Saint Pierre 13005 Marseille, France.
Département de Génétique Médicale, APHM, Hôpital Timone Enfants, Hôpital de la Timone 264 rue Saint Pierre 13005 Marseille, France.

Nathalie Bonello-Palot (N)

Aix Marseille Univ, INSERM, Marseille Medical Genetics, Faculte de médecine, 27 Bd Jean Moulin 13005 Marseille, France.
Département de Génétique Médicale, APHM, Hôpital Timone Enfants, Hôpital de la Timone 264 rue Saint Pierre 13005 Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH